Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population--the future is now?

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):982-3. doi: 10.1002/ccd.26306.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Absorbable Implants*
  • Diabetes Mellitus / drug therapy
  • Drug-Eluting Stents
  • Everolimus*
  • Humans
  • Sirolimus / therapeutic use
  • Tissue Scaffolds
  • Treatment Outcome

Substances

  • Everolimus
  • Sirolimus